2026. Clinically Constrained Multi-Stage Architecture for Integrated Tuberculosis Risk, Drug-Resistance and Severity Assessment. Conference Proceedings in Science and Management. 1, 1 (Oct. 2026), 1–4. DOI:https://doi.org/10.68337/cpsm.v1.i1.2026-001.